| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |